Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 35 (RPL21P35)

Target: RPL21P35
Molecular classification: Other (processed pseudogene)

Overview

RPL21P35 is a processed, non-coding pseudogene related to the ribosomal protein L21 gene. It does not encode a functional protein product[2]. The canonical ribosomal protein L21 is a component of the 60S subunit of the ribosome, involved in protein synthesis in eukaryotes[1]. RPL21P35 shares sequence similarity with RPL21 but is dispersed throughout the genome as a non-functional remnant and is not implicated in any biological pathway, disease process, or as a drug target[2][1][5].

Other names: RPL21P35RPL21_8_333Ribosomal protein L21 pseudogene 35

Mechanism of action

None — mechanisms are not applicable to pseudogenes.

Biological functions

None — pseudogenes generally lack known direct biological function, although some pseudogenes may occasionally play regulatory roles; none are described for RPL21P35

Disease associations

None — the pseudogene is not reported to have disease associations. However, the true RPL21 gene is associated with hypotrichosis simplex of the scalp

Safety considerations

None — as a pseudogene, there are no safety concerns or therapeutic challenges.

Interacting drugs

None — as a pseudogene, there are no known drugs interacting with RPL21P35; drugs do not target processed pseudogenes.

Biomarkers

None — RPL21P35 is not used as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 35 (RPL21P35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 35 (RPL21P35).

Explore the full profile